Research reveals disparities in diabetes drug efficacy for Black populations

New research analyzing the effects of two drugs used to treat type 2 diabetes indicates a consistent lack of cardiovascular and renal benefits in Black populations.

UHS finance chief said company favors patients whose insurance pays more

The country’s largest private psychiatric hospital operator cherry-picks patients whose insurance will pay more, its finance chief said on an earnings call Wednesday. It’s no

July 26, 2023

Inflation reduction act boosts biologic drug venture financing over small molecules – Pharmaceutical Technology

Source: GlobalData, Pharma Intelligence Center, Deals Database (Accessed 21 March 2023). ©GlobalData. US-headquartered biotechs received an overall 19% ($48.9bn) more in venture financing for biologic

June 27, 2023

Safety-focused summary of GLP-1 receptor agonists in diabetes, obesity, and beyond

A recent review in Diabetes Care evaluates the efficacy and safety of GLP-1 receptor agonists for type 2 diabetes and obesity, exploring their potential for

June 18, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.